Cargando…

Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection

BACKGROUND & AIMS: In addition to HBV/HCV causing hepatocellular carcinoma (HCC), other risk factors including obesity and alcohol drinking also increase risk. We describe the cumulative risk of HCC and mortality from liver-related disease by selected modifiable risk factors among a non-hepatiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hui-Chen, Jeng, Wen-Juei, Pan, Mei-Hung, Hsieh, Yi-Chung, Lu, Sheng-Nan, Chen, Chien-Jen, Yang, Hwai-I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777288/
https://www.ncbi.nlm.nih.gov/pubmed/35079699
http://dx.doi.org/10.1016/j.jhepr.2021.100410
_version_ 1784637035102863360
author Wu, Hui-Chen
Jeng, Wen-Juei
Pan, Mei-Hung
Hsieh, Yi-Chung
Lu, Sheng-Nan
Chen, Chien-Jen
Yang, Hwai-I.
author_facet Wu, Hui-Chen
Jeng, Wen-Juei
Pan, Mei-Hung
Hsieh, Yi-Chung
Lu, Sheng-Nan
Chen, Chien-Jen
Yang, Hwai-I.
author_sort Wu, Hui-Chen
collection PubMed
description BACKGROUND & AIMS: In addition to HBV/HCV causing hepatocellular carcinoma (HCC), other risk factors including obesity and alcohol drinking also increase risk. We describe the cumulative risk of HCC and mortality from liver-related disease by selected modifiable risk factors among a non-hepatitis virus-infected population. METHODS: For a community-based cohort, residents aged 30–65 years living in 7 townships in Taiwan were recruited, and have been followed up since 1991. A total of 18,541 individuals were seronegative for markers of chronic infection of HBV/HCV and with no history of HCC at baseline. New non-HBV/HCV HCC cases and liver-related deaths were ascertained through data linkage to the National Cancer Registry and Death Certification System from 1 January 1991 through 31 December 2017. RESULTS: There were 207 HCC cases and 215 liver-related deaths identified. The incidence rate of non-HBV/HCV HCC was 47.2 per 100,000 person-years. The mortality rate of liver-related death was 49.0 per 100,000 person-years. Baseline information on alcohol consumption, heart disease, diabetes, elevated aspartate aminotransferase, and alanine aminotransferase predicted higher risks of HCC, with hazard ratios (HRs) (95% CIs) of 1.7 (1.1–2.5), 2.2 (1.1–4.1), 1.9 (1.0–3.5), 1.7 (1.1–2.4), and 1.6 (1.0–2.4), respectively. The HRs (95% CIs) of liver-related death were 2.3 (1.6–3.2) for alcohol consumption, 1.4 (1.1–1.9) for BMI ≥25 kg/m(2), 2.2 (1.4–3.3) for elevated aspartate aminotransferase, and 1.5 (1.0–2.4) for elevated alanine aminotransferase. The HR (95% CI) was 8.1 (3.6–18.5) for those with diabetes and elevated aspartate aminotransferase. CONCLUSIONS: Individuals with elevated liver enzymes are at high risk of liver disease. Prevention and treatment of diabetes and heart disease are critical for non-hepatitis B, non-hepatitis C (NonB/C)-HCC. LAY SUMMARY: We followed up individuals with no chronic HBV or HCV infection and described the risk of hepatocellular carcinoma (HCC, the most common form of primary liver cancer) and mortality from liver-related disease by modifiable risk factors. This study estimated the incidence rate of HCC by selected lifestyle risk factors and chronic diseases conditions. Alcohol consumption, heart disease, diabetes, and abnormal blood liver function tests showed a strong association with HCC risk and mortality.
format Online
Article
Text
id pubmed-8777288
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87772882022-01-24 Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection Wu, Hui-Chen Jeng, Wen-Juei Pan, Mei-Hung Hsieh, Yi-Chung Lu, Sheng-Nan Chen, Chien-Jen Yang, Hwai-I. JHEP Rep Research Article BACKGROUND & AIMS: In addition to HBV/HCV causing hepatocellular carcinoma (HCC), other risk factors including obesity and alcohol drinking also increase risk. We describe the cumulative risk of HCC and mortality from liver-related disease by selected modifiable risk factors among a non-hepatitis virus-infected population. METHODS: For a community-based cohort, residents aged 30–65 years living in 7 townships in Taiwan were recruited, and have been followed up since 1991. A total of 18,541 individuals were seronegative for markers of chronic infection of HBV/HCV and with no history of HCC at baseline. New non-HBV/HCV HCC cases and liver-related deaths were ascertained through data linkage to the National Cancer Registry and Death Certification System from 1 January 1991 through 31 December 2017. RESULTS: There were 207 HCC cases and 215 liver-related deaths identified. The incidence rate of non-HBV/HCV HCC was 47.2 per 100,000 person-years. The mortality rate of liver-related death was 49.0 per 100,000 person-years. Baseline information on alcohol consumption, heart disease, diabetes, elevated aspartate aminotransferase, and alanine aminotransferase predicted higher risks of HCC, with hazard ratios (HRs) (95% CIs) of 1.7 (1.1–2.5), 2.2 (1.1–4.1), 1.9 (1.0–3.5), 1.7 (1.1–2.4), and 1.6 (1.0–2.4), respectively. The HRs (95% CIs) of liver-related death were 2.3 (1.6–3.2) for alcohol consumption, 1.4 (1.1–1.9) for BMI ≥25 kg/m(2), 2.2 (1.4–3.3) for elevated aspartate aminotransferase, and 1.5 (1.0–2.4) for elevated alanine aminotransferase. The HR (95% CI) was 8.1 (3.6–18.5) for those with diabetes and elevated aspartate aminotransferase. CONCLUSIONS: Individuals with elevated liver enzymes are at high risk of liver disease. Prevention and treatment of diabetes and heart disease are critical for non-hepatitis B, non-hepatitis C (NonB/C)-HCC. LAY SUMMARY: We followed up individuals with no chronic HBV or HCV infection and described the risk of hepatocellular carcinoma (HCC, the most common form of primary liver cancer) and mortality from liver-related disease by modifiable risk factors. This study estimated the incidence rate of HCC by selected lifestyle risk factors and chronic diseases conditions. Alcohol consumption, heart disease, diabetes, and abnormal blood liver function tests showed a strong association with HCC risk and mortality. Elsevier 2021-11-24 /pmc/articles/PMC8777288/ /pubmed/35079699 http://dx.doi.org/10.1016/j.jhepr.2021.100410 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Wu, Hui-Chen
Jeng, Wen-Juei
Pan, Mei-Hung
Hsieh, Yi-Chung
Lu, Sheng-Nan
Chen, Chien-Jen
Yang, Hwai-I.
Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection
title Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection
title_full Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection
title_fullStr Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection
title_full_unstemmed Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection
title_short Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection
title_sort incidence of hepatocellular carcinoma in a community-based taiwanese population without chronic hbv/hcv infection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777288/
https://www.ncbi.nlm.nih.gov/pubmed/35079699
http://dx.doi.org/10.1016/j.jhepr.2021.100410
work_keys_str_mv AT wuhuichen incidenceofhepatocellularcarcinomainacommunitybasedtaiwanesepopulationwithoutchronichbvhcvinfection
AT jengwenjuei incidenceofhepatocellularcarcinomainacommunitybasedtaiwanesepopulationwithoutchronichbvhcvinfection
AT panmeihung incidenceofhepatocellularcarcinomainacommunitybasedtaiwanesepopulationwithoutchronichbvhcvinfection
AT hsiehyichung incidenceofhepatocellularcarcinomainacommunitybasedtaiwanesepopulationwithoutchronichbvhcvinfection
AT lushengnan incidenceofhepatocellularcarcinomainacommunitybasedtaiwanesepopulationwithoutchronichbvhcvinfection
AT chenchienjen incidenceofhepatocellularcarcinomainacommunitybasedtaiwanesepopulationwithoutchronichbvhcvinfection
AT yanghwaii incidenceofhepatocellularcarcinomainacommunitybasedtaiwanesepopulationwithoutchronichbvhcvinfection